Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

Benjamin Waschki,1–3 Henrik Watz,2,3 Olaf Holz,4,5 Helgo Magnussen,2,3 Beata Olejnicka,6 Tobias Welte,5,7 Klaus F Rabe,1,3 Sabina Janciauskiene5,7 1Pneumology, LungenClinic Grosshansdorf, Grosshansdorf, Germany; 2Pulmonary Research Institute at LungenClinic Grosshansdorf, Grosshansdorf, G...

Full description

Bibliographic Details
Main Authors: Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:International Journal of COPD
Subjects:
Plasminogen activator inhibitor 1 (PAI-1)
chronic obstructive pulmonary disease (COPD)
cardiovascular disease
inflammation
hypertriglyceridemia.
Online Access:https://www.dovepress.com/plasminogen-activator-inhibitor-1-is-elevated-in-patients-with-copd-in-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/plasminogen-activator-inhibitor-1-is-elevated-in-patients-with-copd-in-peer-reviewed-article-COPD

Similar Items